Fundz

StairMed secures RMB 500 million in funding led by Alibaba and joined by Tencent for expansion of its brain-machine interface technology.

PRIVATEApr 02, 2026

Amount Raised

¥500 Million

Round Type

Funding Round

BiotechnologyHealth CareMedical

Investors

OrbimedQiming Venture PartnersOriza SeedSource Code CapitalLilly Asia VenturesTencentFountainbridge CapitalAlibaba

Description

Shanghai StairMed Technology Co., Ltd. recently announced a strategic financing round totaling RMB 500 million, led by Alibaba, with participation from Tencent and others. This round enhances StairMed's efforts in developing its brain-machine interface technology and clinical programs. The company has previously completed significant clinical implants of its system

Quick answer

Shanghai StairMed Technology Ltd raised ¥500 Million in a Funding Round round, dated April 2, 2026. Investors: Orbimed, Qiming Venture Partners, Oriza Seed, Source Code Capital, Lilly Asia Ventures, Tencent, Fountainbridge Capital and Alibaba.

How much did Shanghai StairMed Technology Ltd raise?
Shanghai StairMed Technology Ltd raised ¥500 Million in a Funding Round round on April 2, 2026.
Who invested in Shanghai StairMed Technology Ltd?
Orbimed, Qiming Venture Partners, Oriza Seed, Source Code Capital, Lilly Asia Ventures, Tencent, Fountainbridge Capital and Alibaba are named as investors in this round.
What does Shanghai StairMed Technology Ltd do?
Shanghai StairMed Technology Co., Ltd. specializes in brain-machine interface (BMI) technology and is leading advancements in the healthcare sector.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Shanghai StairMed Technology Ltd that raised within 45 days of this round, from Fundz verified event records.

  • Butterfly Medical Ltd raised $21M (Series C) on May 14, 2026.
  • Sedivention raised $3.4M (Seed) on May 7, 2026.
  • Citius Oncology raised $37M on May 6, 2026.
  • Shuttle Pharmaceuticals Holdings raised $10M on April 30, 2026.
  • Nervonik raised $53M (Series B) on April 27, 2026.
  • PlaqueTec raised $5M (Funding Round) on April 27, 2026.

Who to call at Shanghai StairMed Technology Ltd, and when

A new round usually means Shanghai StairMed Technology Ltd is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Shanghai StairMed Technology Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shanghai StairMed Technology Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shanghai StairMed Technology Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shanghai StairMed Technology Ltd

About

Shanghai StairMed Technology Co., Ltd. specializes in brain-machine interface (BMI) technology and is leading advancements in the healthcare sector. They focus on developing innovative systems for brain-controlled interaction, with multiple successful clinical trials. StairMed's recent financing aims to accelerate the clinical development of their proprietary BMI and neuromodulation systems for neurological disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shanghai StairMed Technology Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Shanghai StairMed Technology Ltd's next move

See what Strategic adds

Shanghai StairMed Technology Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.